Follow us:
  1. Home
  2. News
  3. Recalls

Denton Pharma recalls Ranitidine tablets

The medication may be contaminated with a probable cancer-causer

Photo
Photo source: FDA
Denton Pharma, doing business as Northwind Pharmaceuticals, is recalling all unexpired lots of Ranitidine tablets.

The medication, used for treatment of ulcers, may be contaminated with N-nitrosodimethylamine (NDMA), a probable cancer-causer.

Northwind has not received any reports of adverse events to date.

The following product, distributed directly to Northwind Pharmaceuticals and Crosswind Pharmacy, are being recalled:. recall:

ProductNDC
Ranitidine Tablets, USP 150mg70934-017-04
70934-017-20
70934-017-24
70934-017-30
70934-017-90
Ranitidine Tablets, USP 300mg70934-287-15
70934-287-90

The recalled 150-mg product is packaged in unit of use bottle packs of 4’s, 20’s, 24’s, 30’s and 90’s while the 300-mg is packaged in unit of use bottle packs of 15’s and 90’s.

What to do

Patients who have the recalled product should immediately discontinue use, discard remaining product and consult with their physician or healthcare provider about treatment options.

Customers who purchased the recalled product directly from Northwind may call the firm at (800) 722-0772 Monday – Friday, 9:00 am – 5:00 pm (EST) to arrange for product return.

Consumers who have the recalled product should immediately discontinue use, discard remaining product and consult with their physician or healthcare provider about treatment options.

Take a Quiz

Get matched with an Accredited Partner

Share your comments

Get the news you need delivered to you

Sign up to receive our free weekly newsletter. We value your privacy. Unsubscribe easily.

You’re signed up

We’ll start sending you the news you need delivered straight to you. We value your privacy. Unsubscribe easily.